Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
Maini RN, Taylor PC, Szechinski J, Pavelka K, Bröll J, Balint G, Emery P, Raemen F, Petersen J, Smolen J, Thomson D, Kishimoto T; CHARISMA Study Group. Maini RN, et al. Arthritis Rheum. 2006 Sep;54(9):2817-29. doi: 10.1002/art.22033. Arthritis Rheum. 2006. PMID: 16947782 Clinical Trial.
Activation dependent apoptosis of peripheral blood mononuclear cells from patients with rheumatoid arthritis treated with methotrexate.
Swierkot J, Miedzybrodzki R, Szymaniec S, Szechinski J. Swierkot J, et al. Ann Rheum Dis. 2004 May;63(5):599-600. doi: 10.1136/ard.2003.015370. Ann Rheum Dis. 2004. PMID: 15082496 Free PMC article. No abstract available.
Monitoring methotrexate therapy in patients with rheumatoid arthritis.
Wiela-Hojenska A, Orzechowska-Juzwenko K, Swierkot J, Wiland P, Hurkacz M, Szechinski J. Wiela-Hojenska A, et al. Int J Clin Pharmacol Ther. 2004 Aug;42(8):434-41. doi: 10.5414/cpp42434. Int J Clin Pharmacol Ther. 2004. PMID: 15366323
Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab.
Wiland P, Wiela-Hojenska A, Glowska A, Chlebicki A, Hurkacz M, Orzechowska-Juzwenko K, Szechinski J. Wiland P, et al. Clin Exp Rheumatol. 2004 Jul-Aug;22(4):469-72. Clin Exp Rheumatol. 2004. PMID: 15301246
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R. Buttgereit F, et al. Lancet. 2008 Jan 19;371(9608):205-14. doi: 10.1016/S0140-6736(08)60132-4. Lancet. 2008. PMID: 18207016 Clinical Trial.
The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis.
Wiland P, Wojtala R, Goodacre J, Szechinski J. Wiland P, et al. Clin Rheumatol. 2004 Jun;23(3):193-8. doi: 10.1007/s10067-003-0842-y. Epub 2004 Feb 26. Clin Rheumatol. 2004. PMID: 15168143
Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.
Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Li T, Ge Z, Becker JC, Westhovens R. Kremer JM, et al. Ann Intern Med. 2006 Jun 20;144(12):865-76. doi: 10.7326/0003-4819-144-12-200606200-00003. Ann Intern Med. 2006. PMID: 16785475 Clinical Trial.
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2).
Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, Supronik J, Szombati I, Romer U, Witte S, Saag KG. Buttgereit F, et al. Ann Rheum Dis. 2013 Feb;72(2):204-10. doi: 10.1136/annrheumdis-2011-201067. Epub 2012 May 5. Ann Rheum Dis. 2013. PMID: 22562974 Free PMC article. Clinical Trial.
86 results
Jump to page
Feedback